Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction
- 31 July 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 24 (1), 67-73
- https://doi.org/10.1016/0735-1097(94)90543-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up.Circulation, 1993
- Endogenous tissue-type plasminogen activator and risk of myocardial infarctionThe Lancet, 1993
- Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractionsThe Lancet, 1992
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsNew England Journal of Medicine, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjectsMetabolism, 1986
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- THE BIOLOGICAL SIGNIFICANCE OF FIBRINOLYSISThe Lancet, 1956